RecruitingNot applicableNCT04907643
Endocrine
Neuroendocrine tumor of anal canal
2
studies recruiting now
as of 7 Sept 2026
18
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
1 Jun 2021
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT02185443
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases
Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Neuroendocrine tumor of anal canal studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Neuroendocrine tumor of anal canal study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Neuroendocrine tumor of anal canal
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
30 approved treatments and 9 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: OxethazaineApproved: Pramoxine Hydrochloride (Pramoxine hydrochloride component of epifoam)Approved: Fluocortolone (Ficoid 2)Approved: Betamethasone (Betasolan)Approved: Fluorometholone (Fluaton)Approved: Procaine (Solution of novocain)Approved: Isosorbide Dinitrate (Angitak)Approved: Phenylephrine Hydrochloride (Afrin 4 hour nasal spray)Approved: Menthol (Aqua-cool)Approved: TribenosideApproved: Benzocaine (Aezodent)Approved: Hydrocortisone (Acetasol hc)Approved: Witch Hazel (Demada lotio derm)Approved: Fluocinolone Acetonide (Capex)Approved: PhenylephrineApproved: Tannic Acid (Tannic acid component of depinar)Approved: Morrhuate SodiumApproved: Tetracaine (Ametop)Approved: Dexamethasone (Aeroseb-dex)Approved: Glycerin (Glycerin component of monoctanoin d)Approved: DibucaineApproved: Diosmin (Diovenor)Approved: DiltiazemApproved: Prednisolone (Cortalone)Approved: Lidocaine (Alphacaine)Approved: Fluocinonide (Fluocinonide)Approved: Zinc Oxide (Anusol)Approved: Triamcinolone (Aristocort)Approved: PramoxineApproved: Nitroglycerin (Coro-nitro)
Phase 3Bupivacaine (Anekain)
Phase 3Bupivacaine Hydrochloride (Bupivac hcl)
Phase 3Metronidazole (Acea)
Phase 3Water (Pur-wash)
Phase 3Iferanserin
Phase 2/3Polidocanol (Aethoxysklerol)
Phase 2Hydrocortisone Acetate (Barquinol hc)
Phase 2Lidocaine Hydrochloride (Akten)
+ 1 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).